[go: up one dir, main page]

DE122008000004I2 - Formulierung zur peptidfreisetzung - Google Patents

Formulierung zur peptidfreisetzung

Info

Publication number
DE122008000004I2
DE122008000004I2 DE122008000004C DE122008000004C DE122008000004I2 DE 122008000004 I2 DE122008000004 I2 DE 122008000004I2 DE 122008000004 C DE122008000004 C DE 122008000004C DE 122008000004 C DE122008000004 C DE 122008000004C DE 122008000004 I2 DE122008000004 I2 DE 122008000004I2
Authority
DE
Germany
Prior art keywords
formulation
relief
peptide
deslorelin
mug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE122008000004C
Other languages
English (en)
Other versions
DE122008000004I1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Peptech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Ltd filed Critical Peptech Ltd
Publication of DE122008000004I1 publication Critical patent/DE122008000004I1/de
Publication of DE122008000004I2 publication Critical patent/DE122008000004I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DE122008000004C 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung Active DE122008000004I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN3667A AUPN366795A0 (en) 1995-06-20 1995-06-20 Formulation for preventing reproductive function
PCT/AU1996/000370 WO1997000693A1 (en) 1995-06-20 1996-06-20 Novel formulation for peptide release

Publications (2)

Publication Number Publication Date
DE122008000004I1 DE122008000004I1 (de) 2008-04-17
DE122008000004I2 true DE122008000004I2 (de) 2009-08-06

Family

ID=3788008

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69623652T Expired - Lifetime DE69623652T2 (de) 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung
DE122008000004C Active DE122008000004I2 (de) 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69623652T Expired - Lifetime DE69623652T2 (de) 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung

Country Status (16)

Country Link
US (2) US5925619A (de)
EP (1) EP0871467B1 (de)
JP (1) JP4016133B2 (de)
CN (1) CN1145496C (de)
AT (1) ATE223726T1 (de)
AU (2) AUPN366795A0 (de)
CA (1) CA2225796C (de)
DE (2) DE69623652T2 (de)
DK (1) DK0871467T3 (de)
ES (1) ES2182983T3 (de)
FR (1) FR08C0001I2 (de)
NL (1) NL300330I2 (de)
NZ (1) NZ309697A (de)
PT (1) PT871467E (de)
SI (1) SI0871467T1 (de)
WO (1) WO1997000693A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
WO1998008533A1 (en) * 1996-08-30 1998-03-05 Peptech Limited Sustained peptide-release formulation
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
ES2389627T3 (es) * 1998-07-20 2012-10-29 Virbac (Australia) Pty Ltd Formulación para bioimplantes
US6211221B1 (en) * 1999-04-05 2001-04-03 Johnny W. Peterson Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor
EP1330257B1 (de) * 2000-10-30 2005-08-31 University Of Zurich Verwendung von gnrh-analogue zur behandlung der harninkontinenz
GB0221539D0 (en) * 2002-09-17 2002-10-23 Medical Res Council Methods of treatment
US20060003008A1 (en) * 2003-12-30 2006-01-05 Gibson John W Polymeric devices for controlled release of active agents
CA2590239A1 (en) * 2004-12-23 2006-07-06 Durect Corporation Controlled release compositions
EP2187914A2 (de) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Astressin und beta-endorphin zur verwendung als therapeutische mittel
DE102008015104A1 (de) 2008-03-19 2009-09-24 Basf Coatings Ag Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (de) * 1972-10-12 1981-01-27
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
ATE74009T1 (de) * 1986-08-11 1992-04-15 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function

Also Published As

Publication number Publication date
US6211152B1 (en) 2001-04-03
ES2182983T3 (es) 2003-03-16
CA2225796A1 (en) 1997-01-09
FR08C0001I1 (de) 2008-03-21
FR08C0001I2 (de) 2009-11-20
AU5992796A (en) 1997-01-22
CN1145496C (zh) 2004-04-14
NL300330I1 (nl) 2008-03-03
DE69623652T2 (de) 2003-05-28
SI0871467T1 (en) 2003-08-31
WO1997000693A1 (en) 1997-01-09
AUPN366795A0 (en) 1995-07-13
DK0871467T3 (da) 2002-12-23
JP2001521482A (ja) 2001-11-06
EP0871467A4 (de) 2000-07-05
CN1188414A (zh) 1998-07-22
ATE223726T1 (de) 2002-09-15
DE69623652D1 (de) 2002-10-17
HK1014874A1 (en) 1999-10-08
JP4016133B2 (ja) 2007-12-05
US5925619A (en) 1999-07-20
CA2225796C (en) 2011-09-20
AU701837B2 (en) 1999-02-04
EP0871467B1 (de) 2002-09-11
EP0871467A1 (de) 1998-10-21
DE122008000004I1 (de) 2008-04-17
NL300330I2 (nl) 2008-04-01
PT871467E (pt) 2002-12-31
NZ309697A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
FR08C0001I2 (de)
AU4718496A (en) Use of aerogels in agriculture
FI963696A0 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
MY113488A (en) Compounds with growth hormone releasing properties
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
AU2840789A (en) Continuous release pharmaceutical compositions
DE69532921D1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
MY138883A (en) Use of asiatic acid for treatment of cencer
ES2154693T3 (es) Combinacion de sustancias inductoras de necrosis con sustancias que son activadas por necrosis, para la terapia selectiva de tumores y enfermedades inflamatorias.
MY164077A (en) Compositions and uses of et743 for treating cancer
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
AU5643299A (en) Humic acid and its use in the treatment of various conditions
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
WO1994020115A3 (en) Hyaluronic acid used as a cancer treatment
EP0539516A4 (de)
UA30723A (uk) Спосіб лікування аутоімунних захворювань
GR1002955B (el) Προιοντα που προερχονται απο το φυτο κυπαρισσος και ολα τα συγγενη κωνοφορα, για χρηση στην προληψη και θεραπεια καθε τυπου υπερχοληστεριναιμιας και διαταραχης λιπιδιων, σε ανθρωπους και ζωα
UA7163A (uk) Спосіб відновлення ушкоджених тканин людини чи тварини
UA36126A (uk) Бандаж поперековий
BG51699A1 (en) Stimulating fertility agent
UA10825A (uk) Протимікробhий засіб
IT1245148B (it) Glicoproteine estratte da apparati riproduttori femminili, loro uso in dermatologia e cosmesi della pelle e delle mucose
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.